Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Study ID
- NCT05772637
- Status
- Recruiting
Conditions
- Overactive Bladder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Repeated cystometries with bladder sensations assessment — PROCEDUREA second cystometry will be performed to assess bladder sensations reliability. A third cystometry with cognitive task (STROOP test) at the same time will be performed to assess the impact of distractive attentional task on bladder sensations
Study Details
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.
Key Dates
- First listed
- Mar 16, 2023
- Start date
- Feb 14, 2024
- Status verified
- Mar 2026
- Primary completion
- Feb 14, 2027
- Completion
- Feb 14, 2027
Study Design
- Enrollment
- 113 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: MS Patient with Bladder disorders
Primary Outcome Measure
bladder sensation ( area under the sensation-capacity curve (AUC)) [ Time Frame: Day 1 ]
Central Contacts
- Claire Hentzen, MD0156017500
- Gérard AMARENCO, MD, PhD0156017500
Related Studies
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive BladderPHASE4 · Recruiting · Walter Reed National Military Medical Center · Bethesda, Maryland
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruiting · Loma Linda University · Loma Linda, California
- Antibiotic Usage Prior to OnabotulinumtoxinA InjectionRecruiting · Benaroya Research Institute · Stony Brook, New York
- BTL Emsella Chair Versus Sham for the Treatment of Overactive BladderRecruiting · Corewell Health East · Royal Oak, Michigan